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Abstract
Background: Muscarinic acetylcholine receptors (mAChRs) have been identified in airway epithelium, and
epithelium-derived chemokines can initiate the migration of airway smooth muscle (ASM) cells. However, the
mAChRs that are expressed in airway epithelium and the mechanism underlying the regulation of ASM cell
migration are not clear. The aim of this study was to test whether the effects of the epithelium-derived
chemokines on ASM cell migration could be modulated by mAChRs.
Method: Human epithelial cells (A549 cells) were stimulated with cigarette smoke extract (CSE) or the mAChRs
agonist carbachol. IL-8 and TGF-β1 production were measured by ELISA, and human ASM cell migration was
measured using the transwell migration assay and scratch assay. The mRNA levels of the mAChRs subtypes and
the acetylcholine concentrations were measured using RT-PCR and LC–MS/MS, respectively.
Results: ASM cell migration toward CSE-stimulated A549 cells was markedly reduced by Ac-RRWWCR-NH2
(IL-8 inhibitor) and SB431542 (TGF-β1 inhibitor). CSE-induced ASM cell migration was also suppressed by the
mAChRs antagonist tiotropium. Interestingly, carbachol-stimulated A549 cells also induced ASM cell migration;
this migration event was suppressed by tiotropium, Ac-RRWWCR-NH2 and SB431542. In addition, the effects of
CSE on ASM cell migration were significantly and cooperatively enhanced by carbachol compared to CSE alone.
Carbachol-induced ASM cell migration was reduced by selective inhibitors of PI3K/Akt (LY294002) and p38
(SB203580), suggesting that it occurred through p38 and Akt phosphorylation, which was inhibited by the M3
mAChR antagonist 4-DAMP.
Conclusions: These findings indicate that M3 mAChR may be important therapeutic target for obstructive airway
diseases, as it regulates the effects of the epithelial-derived chemokines on ASM cell migration, which results in
lung remodeling.
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Background
Airway remodeling is one of the major features of many
obstructive airway diseases, and has been observed both
in asthma and in chronic obstructive pulmonary disease
(COPD) [1, 2]. The adverse consequences of airway
remodeling could include a decrease in lung function
and reduced responsiveness to bronchodilator therapy.
Different mechanisms were proposed to explain smooth
muscle remodeling, including proliferation (hyperplasia),
an increase in myocyte mass and size and an increase in
their components as a response to injury or inflamma-
tion [3, 4]. However, many studies have suggested that
the migration of ASM cells toward the lumen of the air-
way might contribute to ASM remodeling [5–10] and
plays an important role in the pathophysiology of airway
remodeling [8, 9, 11–13].
It has been reported that cigarette smoke or cigarette
smoke condensate induced tracheal and lung epithelial
cell damage and shedding. Lung epithelial cells are not
only the simple structural cells of the lung but also serve
as a barrier for inhaled particles and noxious gases
(such as cigarette smoke). These cells are also actively
involved in inflammatory and repair processes through
the release of cytokines and growth factors that main-
tain normal airway homeostasis and play an important
role in the prevention of pulmonary diseases. Airway
remodeling may represent the effect of cigarette smoke
on the epithelium and the attempts by the airway epi-
thelium to protect itself and repair the injury caused
by cigarette smoke. The human alveolar epithelial cell
line A549 (A549) is widely acknowledged to be a rele-
vant model cell line for biological evaluations of this
mechanism [14, 15].
Airway smooth muscle (ASM) cells are associated with
asthma severity and COPD and have the capacity to
migrate. Many chemokines, such as growth factors and
cytokines, have been implicated in the initiation and the
perpetuation of ASM cell migration [11, 16]. In fact, a
strong relationship between chronic injury or defective
repair of the airway epithelium and airway remodeling
has been reported in the literature [17]. Not surprisingly,
the epithelium is a major source of the cytokines and
growth factors that act as mitogens for ASM cells,
such as IL-8 and TGF-β1. More important to the
study of epithelial-ASM cell interactions, the receptors
for epithelial-derived growth factors and cytokines,
such as TGF-β1 and IL-8, were identified on the ASM
cell surface [18, 19]. Increased expression of the TGF-
β1 and IL-8 mRNAs and proteins has been observed
in the bronchiolar epithelium of smokers with COPD
compared to smokers without COPD [20–22]. The ex-
pression of TGF-β1 at the injury site may have a cen-
tral role in tissue homeostasis and repair. IL-8 is a
potent neutrophil chemoattractant [23] and a potential
contributor to airway remodeling, as it induces airway
smooth muscle proliferation and migration [16].
Airway epithelial damage exposes the sensory nerve
endings to the airway lumen and promotes reflex
mechanisms, leading to enhanced vagal release of acetyl-
choline [24]. Recent findings suggest that the acetylcholine
production in the airways is not restricted to the parasym-
pathetic nervous system, but can also be released from
non-neuronal cells and tissues, such as the airway epithe-
lium, to regulate aspects of inflammation and remodeling
through its action on mAChRs [25–29]. Dysfunction
of the non-neuronal cholinergic system appears to be
involved in the pathophysiology of asthma and COPD.
Although a number of molecules that are involved in
acetylcholine-mediated airway inflammation and remodel-
ing have been identified, the net effect of mAChRs in
regulating epithelial-derived chemokine-induced ASM cell
migration has not been explored in great detail.
The aim of the present study was to characterize the
potential role of the non-neuronal components of the
cholinergic system on ASM cell migration toward bron-
chial epithelial cells stimulated with CSE. For this reason,
we first evaluated whether the IL-8 and TGF-β1 from the
CSE-stimulated epithelial cells might be able to initiate
ASM cell migration using the transwell assay and the
co-culture model of human ASM cells and A549 cells.
Then, we tested whether the ability of CSE to induce
the ASM cell migration might be regulated by mAChRs




The A549 cells obtained from the American Type Culture
Collection (Manassas, VA, USA) and the normal primary
human airway smooth muscle cells (passage 3-8, from a
single healthy donor) obtained from Pricell Inc. (Shanghai,
China) were cultured in Ham’s F-12 medium (Gibco, USA)
and Dulbecco’s Modified Eagle’s Medium (DMEM), re-
spectively, containing 10 % fetal bovine serum, L-glutamine
(2 mM), penicillin (100 U/ml) and streptomycin sulfate
(100 U/ml, Gibco, USA) in a humidified incubator at 37 °C
with 5 % CO2.
Cigarette Smoke Extract (CSE)
The CSE was prepared as previously described, with
minor modifications [30]. The CSE was prepared by
combusting 1 cigarette (double happiness, the amount
of tar was 12 mg), using a pump and passing the smoke
through 10 ml of FBS-free culture medium at a rate of
5 min/cigarette. The resulting solution was adjusted to
pH 7.4 with 1 mol/L of concentrated NaOH and filtered
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through a 0.22-μm filter. The obtained solution was re-
ferred to as 100 % strength and diluted to the desired
concentrations with culture medium.
Measurement of the IL-8 and TGF-β1 produced by the
A549 cells
After serum deprivation for 24 h before each experiment,
the cells were pre-treated with tiotropium (Sigma–
Aldrich, USA) for 30 min before 3 % CSE stimulation, or
treated with different concentrations of carbachol alone.
After 72 h, the concentrations of IL-8 and TGF-β1 in the
culture supernatants were immediately measured using an
ELISA kit (R&D Systems, Minneapolis, MN) according to
the manufacturer’s protocol.
Cell migration assay
We jointly applied transwell migration chamber assay
and scratch assay to examine the ASM cell migration in-
duced by epithelial derived supernatants. For transwell
migration chamber assay, the A549 cells were cultured
in the lower wells (omitted in the negative control) at
densities of 100,000 cells/cm2 and grown to 80 % conflu-
ence, followed by serum-deprivation for 24 h before each
experiment. Subsequently, the cells were treated with
carbachol or 3 % CSE for 72 h. Tiotropium (Tio, 0.1, 1,
10 μM) and 4-DAMP (10 μM, selective M3 mAChR
antagonist) were added to the cells 30 min before CSE
stimulation and were present throughout the experiment.
Additionally, where appropriate, the A549 cells were pre-
incubated with either the IL-8 inhibitor Ac-RRWWCR-
NH2 (AnaSpec, Inc., Fremont, Calif ) or the TGF-β1
inhibitor SB431542 (Sigma–Aldrich, USA) for 30 min.
The ASM cells (30,000 cells/cm2) were added to the
upper chambers. The vehicle was DMSO and the final
concentration of DMSO was 0.1 % in all wells, including
the controls. After incubating the cells for 6 h at 37 °C,
the upper chamber was removed from the 24-well plates
and the residual cells on the upper side of the transwell
filters were wiped with cotton swab. The transwell
filters were rinsed with PBS and fixed in 4 % formalde-
hyde in PBS for 15 min. The cells that had migrated to
the lower surface were stained with 0.1 % crystal violet
for 25 min, visualized and photographed under an
inverted fluorescence microscope (Zeiss, Germany).
The migration rate was analyzed using the Image Pro
Plus 6.0 software.
For scratch assay, the confluent A549 cells were stimu-
lated with 3 % CSE for 72 h with the pretreatment of
Ac-RRWWCR-NH2 and SB431542. Then, the superna-
tants were collected as stimulants for ASM cell migration.
ASM cells were cultured in DMEM until 100 % conflu-
ence and then wounded with a sterile 20 μL pipette tip.
Subsequently, the cells were washed with PBS and treated
with the epithelial derived supernatants. The wounds were
photographed at baseline and 24 h later under an inverted
fluorescence microscope (AMG, America). The wound
healing width was analyzed using the Image Pro Plus 6.0
software.
Determination of the acetylcholine levels by LC-MS/MS
The acetylcholine levels in the supernatants from the
A549 cells were determined by LC–MS/MS, as previ-
ously described [31].
Real-time quantitative PCR of the mAChRs
The A549 cells were stimulated with 3 % CSE for 24, 48
or 72 h. The expression of the mAChRs was detected by
Real-time quantitative PCR (RT-PCR), as previously
described [31].
Western blot analysis
Equal amounts of protein were loaded onto 10 % SDS-
PAGE gels and transferred to polyvinylidene fluoride
membranes. To avoid non-specific binding, the mem-
branes were blocked with 5 % non-fat milk in TBS-T
(Tris-HCl 50 mM, NaCl 150 mM, and Tween-20 0.1 %)
for 1 h at room temperature. The membranes were then
incubated with primary antibodies against phosphorylated-
p38 (#4511; Cell Signaling Technology, USA) or phos-
phorylated-Akt (#4060; Cell Signaling Technology, USA)
overnight at 4 °C. After washing three times with TBS-T
for 10 min, the membranes were incubated with an HRP-
conjugated secondary antibody (1:5000) for 1 h at room
temperature, followed by three additional washes with
TBS-T. The bands were subsequently visualized on film
using enhanced chemiluminescent reagents. All bands
were normalized against the total p38 (for phospho-p38)
and total Akt (for phospho-Akt) levels, as appropriate. In
the experiments designed to establish whether the p38
MAPK or PI3K/Akt pathways were involved in the ASM
cell migration induced by the mAChRs agonist carbachol,
a p38 inhibitor (SB203580: 10 μM) or a PI3K/Akt inhibitor
(LY294002: 10 μM) was added to the culture 1 h prior to
stimulation.
Statistical analysis
The data are presented as the means ± SEM. The statis-
tical significance of the differences between groups was
assessed with one-way analysis of variance (ANOVA),
followed by a Dunnett’s test for selected pairs, as appro-
priate. p-values <0.05 were considered significant. All
statistical analyses were performed using Prism version
5.0 (GraphPad Software, San Diego, USA).
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Fig. 1 (See legend on next page.)
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Results
The role of IL-8 and TGF-β1 from the CSE-stimulated
epithelial cells in initiating ASM cell migration
The A549 cells that had been activated with 3 % CSE
exhibited increased IL-8 and TGF-β1 levels in the super-
natants, resulting in ASM cell migration toward the
A549 cells. The IL-8 or TGF-β1 levels in supernatants
were increased by approximately 2.23-fold and 1.89-fold,
respectively, in response to CSE stimulation (p <0.01),
that effect was markedly inhibited by tiotropium in a
concentration-dependent manner (Fig. 1a and b). We
also used the transwell assay and the scratch assay to
further assess whether CSE-induced ASM cell migration
was initiated by IL-8 or TGF-β1. The IL-8 inhibitor Ac-
RRWWCR-NH2 or the TGF-β1 inhibitor SB431542 was
added to the lower chamber of the transwell system (A549
epithelial cells). As expected, the results from transwell
migration assay suggested that Ac-RRWWCR-NH2 and
SB431542 decreased ASM cell migration ratio by 81.06
and 75.81 % (p <0.01) compared to the non-treated cells,
indicating that the compounds inhibited ASM cell migra-
tion (Fig. 1c and d). As results of transwell assay, scratch
assay also demonstrated that supernatants from CSE-
stimulated epithelial cells induced ASM cell migration,
this phenomenon was significantly inhibited by both Ac-
RRWWCR-NH2 and SB431542 (Fig. 1e and f), suggesting
that the IL-8 and TGF-β1 from the CSE-stimulated
A549 cells have an important role in driving ASM cell
migration.
Blockade of the epithelial cell-derived chemokines by an
mAChRs antagonist reduces ASM cell migration
As airway epithelial cells exhibit all components of the
non-neuronal cholinergic system, we investigate the
involvement of this system in the control of ASM cell
migration in response to the epithelial cell-derived
chemokines. The A549 cells were pre-incubated with
the mAChRs antagonist tiotropium which was added
30 min before CSE stimulation. As shown in Fig. 2, the
CSE-stimulated A549 cell-induced ASM cell migration was
significantly reduced by tiotropium in a concentration-
dependent manner. The ability of tiotropium (0.1, 1,
10 μM) to regulate the ASM cell migration was 37.53,
69.32 and 89.96 % lower than the cells treated with 3 %
CSE alone, respectively, suggesting that the endogenous
(See figure on previous page.)
Fig. 1 The role of IL-8 and TGF-β1 from CSE-stimulated epithelial cells in initiating ASM cell migration. Tiotropium (Tio, 0.1, 1, 10 μM) was added
to the A549 cells 30 min before stimulation with 3 % CSE. After 72 h of stimulation, the supernatants were collected and the IL-8 (a) and TGF-β1
(b) concentrations were determined using an ELISA. ASM cell migration initiated by the A549 cells stimulated with 3 % CSE were reduced by the
IL-8 inhibitor Ac-RRWWCR-NH2 and the TGF-β1 inhibitor SB431542. Cell migration was detected by using transwell chamber assay (c, ×100) and
scratch assay (e, ×100). A quantitative analysis of migration used Image Pro Plus 6.0 (d and f). The values are expressed as the means ± SEM,
n = 3-5. ††p < 0.01 vs the control group, *p < 0.05 and **p < 0.01 vs the CSE group
Fig. 2 Effects of tiotropium on ASM cell migration initiated by the
A549 cells stimulated with CSE. The A549 cells were stimulated with
3 % CSE for 72 h. Tio (0.1, 1, 10 μM) was added to the cells 30 min
before 3 % CSE stimulation and was present throughout the
experiment. ASM cell migration initiated by the stimulated A549
cells was detected after 6 h of co-culture in the transwell system,
the migrated ASM cells were stained with crystal violet (a, ×100). A
quantitative analysis of migration used Image Pro Plus 6.0 (b). The
values are expressed as the means ± SEM, n = 3. ††p < 0.01 vs the
control group. *p < 0.05 and **p < 0.01 vs the CSE group
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acetylcholine exerts its activity by activating the mAChRs
on the epithelial cells.
Involvement of the non-neuronal cholinergic system in
epithelial-derived chemokine-mediated ASM cell
migration
If the non-neuronal cholinergic system in epithelial
cells is indeed involved in the epithelial cell-derived
chemokine-mediated ASM cell migration, we hypothe-
sized that the application of exogenous mAChRs agonists
would reproduce the effect of endogenous acetylcholine.
To verify this hypothesis, the A549 cells were first stimu-
lated with the acetylcholine analogue carbachol. As shown
in Fig. 3, stimulation of the A549 cells with the mAChRs
agonist carbachol increased IL-8 (Fig. 3a) and TGF-β1
(Fig. 3b) levels and induced concentration-dependent
ASM cell migration, which could be inhibited by the IL-8
inhibitor Ac-RRWWCR-NH2 and the TGF-β1 inhibitor
SB431542, respectively (Fig. 3c and d). Moreover,
carbachol-induced ASM cell migration was significantly
reduced by tiotropium (10 μM) (p <0.01) and 4-DAMP
(10 μM) (p <0.01) (Fig. 4). These results strongly sup-
port our hypothesis that endogenous acetylcholine may
stimulate the M3 mAChR in A549 cells to promote
ASM cell migration. We also found that the stimulation
of A549 cells with CSE increased the expression of the
M3 mAChR mRNA (Fig. 5a), as well as acetylcholine
production. Interestingly, we also found that CSE-
induced acetylcholine release was increased by 42.34 %
in the presence of a cholinesterase inhibitor neostigmine,
which did not affect acetylcholine release when using
alone (Fig. 5b). Because the inducing effect of endogenous
Fig. 3 The carbachol-stimulated A549 cells induced IL-8 and TGF-β1 release and ASM cell migration. The A549 cells were stimulated with carbachol
(CCh, 0.1, 1, 10 μM) in the presence or absence of the IL-8 inhibitor Ac-RRWWCR-NH2 and the TGF-β1 inhibitor SB431542 for 72 h. Then, the
supernatants were collected and the IL-8 (a) and TGF-β1 (b) concentrations were determined using an ELISA. ASM cell migration initiated by
the stimulated A549 cells was detected after 6 h of co-culture in the transwell system, the migrated ASM cells were stained with crystal violet
(c, ×100). A quantitative analysis of migration used Image Pro Plus 6.0 (d). The values are expressed as the means ± SEM, n = 5–8. †p < 0.05
and ††p < 0.01 vs the control group, **p < 0.01 vs the CCh (10 μM) group, ‡‡p < 0.01 vs the CCh (10 μM) group
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acetylcholine could be reproduced by an exogenous
mAChRs agonist, we further hypothesized that the stimu-
latory effect of CSE on ASM cell migration could be
enhanced by carbachol. Thus, co-incubation experiments
were performed using carbachol (10 μM) and 3 % CSE.
CSE-induced ASM cell migration was significantly and co-
operatively enhanced by carbachol compared to the cells
stimulated with CSE alone. And a synergistic effect of CSE
plus carbachol on ASM cell migration was observed in
comparison with CSE or carbachol alone (Fig. 6). The
enhancing effect of carbachol prompts us to propose that
an autocrine/paracrine loop for acetylcholine and the acti-
vation of M3 mAChR regulates ASM cell migration.
The role of the p38 and PI3K/Akt signaling pathways in
mAChR-mediated ASM cell migration
To better understand how mAChRs mediated ASM cell
migration, the downstream signaling pathways that were
activated by the mAChR agonist or CSE were investigated.
We first assessed the relationship between mAChR activa-
tion and the p38 and PI3K/Akt pathways on ASM cell
migration using an mAChR agonist and antagonist. As
Fig. 4 Effects of the mAChR antagonists on carbachol-induced ASM
cell migration. The A549 cells were stimulated with CCh (10 μM) for
72 h. Tio (10 μM) or 4-DAMP (10 μM) was added to the cells 30 min
before CCh stimulation and was present throughout the experiment.
ASM cell migration initiated by the stimulated A549 cells was detected
after 6 h of co-culture in the transwell system, the migrated ASM cells
were stained with crystal violet (a, ×100). A quantitative analysis of
migration used Image Pro Plus 6.0 (b). The values are expressed as
the means ± SEM, n = 4. ††p < 0.01 vs the control group. **p < 0.01
vs the CCh group
Fig. 5 Effects of the CSE on acetylcholine release and the mRNA
levels of M1, M2, M3. a Neostigmine (10 μM) was added to the A549
cells 1 h before stimulation with 3 % CSE. The acetylcholine (ACh)
levels were determined after 72 h co-culture using an LC-MS/MS
assay. b The A549 cells were incubated with 3 % CSE for 24, 48,
72 h, and the mRNA levels were determined using a quantitative
RT-PCR and standardized to that of the GAPDH gene. The values are
expressed as the means ± SEM. n = 3-5. *p < 0.05 and **p < 0.01 vs
the control group
Lu et al. Respiratory Research  (2016) 17:25 Page 7 of 11
shown in Fig. 7a and b, the phosphorylation of both p38
and Akt was increased by the mAChR agonist carbachol
(10 μM, p <0.05) and CSE-induced phosphorylation of
p38 and PI3K/Akt were enhanced by carbachol (p <0.01).
In addition, the carbachol- or carbachol plus CSE-induced
phosphorylation of p38 and Akt was significantly inhibited
by 4-DAMP, suggesting that there is a relationship be-
tween the M3 mAChR and the p38 and PI3K/Akt path-
ways in ASM cell migration. Specific inhibitors of p38 and
PI3K/Akt were used to further confirm the contribution
of p38 and PI3K/Akt activation to ASM cell migration. As
shown in Fig. 7c and d, SB203580 (10 μM, p <0.01) and
LY294002 (10 μM, p <0.01) caused marked reductions in
carbachol-induced ASM cell migration, suggesting that
the p38 and PI3K/Akt signaling pathways are required
for ASM cell migration. These findings indicated that
the p38 and PI3K/Akt signaling pathways are involved
in carbachol-induced ASM cell migration via the M3
mAChR in the A549 cells.
Discussion
This study demonstrates that the endogenously released
acetylcholine stimulates the M3 mAChR in the airway
epithelial cells via an autocrine loop and thus leads to the
release of IL-8 and TGF-β1, initiating ASM cell migration.
Moreover, the p38 and PI3K/Akt signaling pathways are
involved in carbachol-induced ASM cell migration via the
M3 mAChR in the A549 cells. These findings indicate that
the M3 mAChR may be important therapeutic target as it
regulates the effects of the epithelial-derived chemokines
on ASM cell migration during lung remodeling.
Airway remodeling is the result of tissue injury and re-
pair, and involves the interactions between a variety of
structural cells, including epithelial cells and ASM cells.
Some growth factors and cytokines have been reported
as the chemokines for ASM cells [12, 13, 32]. Cigarette
smoking causes direct lung damage, as well as the acti-
vation of the lung inflammatory responses and airway
remodeling pathways that are important in the etiology
of the development of asthma and COPD. The epithelium
is a significant source of chemokines, such as cytokines
and growth factors. The exposure of epithelial cells to the
CSE induced the production of these chemokines, which
play an important role in inducing ASM cell migration
toward the epithelial surface and contribute to airway
remodeling. TGF-β1 and IL-8, important chemokines, are
known to be released by epithelial cells following cigarette
smoke exposure [33–35]. In the present study, we showed
that the CSE-stimulated A549 epithelial cells released IL-8
and TGF-β1, resulting in ASM cell migration toward the
epithelial cells. The migratory effect was substantially
inhibited by Ac-RRWWCR-NH2 (IL-8 inhibitor) and
SB431542 (TGF-β1 inhibitor), suggesting that these
chemokines may initiate ASM cell migration.
Interestingly, we have shown that the migration of
the ASM cells is induced by the chemokines from the
stimulated A549 epithelial cells and could be reduced by
treatment with non-selective (tiotropium) and selective (4-
DAMP) antagonists of the M3 mAChR. To date, five
mAChR subtypes have been identified (M1-M5) and are
thought to mediate the majority of the actions of acetyl-
choline in the peripheral and central nervous systems. Of
these, M1, M2 and M3 are expressed at the highest levels
in the airways and subserve different physiological func-
tions [36]. The presence of endogenously released acetyl-
choline stimulates the M3 mAChR via an autocrine loop
and thus modulates the functions of the airway epithelial
cells, as was previously reported by our and other la-
boratories [31, 37, 38]. Our observation of the predomin-
ant expression of the M3 mRNA by the A549 epithelial
cells is consistent with other reports showing that a human
Fig. 6 Enhancement of ASM cell migration by co-stimulating the
A549 cells with CSE and carbachol. The A549 cells were incubated
with 3 % CSE and CCh (10 μM) for 72 h. ASM cell migration initiated
by the stimulated A549 cells was detected after 6 h of co-culture in
the transwell system, the migrated ASM cells were stained with crys-
tal violet (a, ×100). A quantitative analysis of migration used Image
Pro Plus 6.0 (b). The values are expressed as the means ± SEM, n = 4.
*p < 0.05 and **p < 0.01 vs the control group
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bronchial epithelial cell line (16-HBE) expressed both the
proteins and mRNAs for the M1, M2 and M3 mAChRs,
with the following levels: M3 >M1 >M2 mAChRs [39].
The CSE increases the activity of the chemokines from the
human epithelial cells and promotes the cellular response
to acetylcholine by affecting the M3 mAChR. The fact that
the carbachol-induced migration of the ASM cells toward
the A549 epithelial cells blocked by 4-DAMP confirmed
the involvement of the M3 mAChR. A synergistic effect of
carbachol and CSE on ASM cell migration was also ob-
served in this study. Furthermore, tiotropium could prevent
the carbachol (acetylcholine analogue)- and CSE-induced
ASM cell migration toward the epithelial surface. This
finding further demonstrates that the repertoire of
mAChR subtypes in the A549 epithelial cells is modified
by CSE stimulation, and the M3 mAChR is significantly
up-regulated. Therefore, it is reasonable to assume that
the CSE-induced up-regulation of M3 mAChR expression
observed in the present study increases the A549 cells’
response to acetylcholine.
The application of the mAChRs antagonists tiotropium
or 4-DAMP reduced the CSE-induced ASM cell migration
Fig. 7 The involvement of the p38 MAPK and PI3K/Akt pathways in ASM cell migration. a and b The A549 cells were co-incubated with CCh
(10 μM) or 3 % CSE for 72 h after pretreatment with 4-DAMP (10 μM). Then the cell lysates were assayed for the levels of total and phosphorylated p38
and Akt; the total p38 and Akt levels were used as a loading control. The A549 cells were incubated with CCh (10 μM) for 72 h after pretreatment with
LY294002 (10 μM) or SB203580 (10 μM). ASM cell migration initiated by the stimulated A549 cells was detected after 6 h of co-culture in the transwell
system, the migrated ASM cells were stained with crystal violet (c, ×100). A quantitative analysis of migration used Image Pro Plus 6.0 (d). The values
are expressed as the means ± SEM. n = 4–6. †p < 0.05 and ††p < 0.01 vs the control group, *p < 0.05 and **p < 0.01 vs the corresponding group without
4-DAMP. ‡‡p < 0.01 vs the CCh group
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in the absence of exogenous mAChRs ligands or choliner-
gic neurons in the culture preparations. This finding sug-
gests that the levels of endogenous acetylcholine that are
released by the CSE-stimulated A549 epithelial cells are
sufficient to exert its autocrine effects via the stimulation
of the M3 mAChR. The release of endogenous acetylcho-
line was also demonstrated by ASM migration toward the
epithelial cells treated with the cholinesterase inhibitor
neostigmine, which increased the concentration of acetyl-
choline in the supernatant, suggesting that cholinesterase
activities are involved in acetylcholine degradation and
constitute an active, endogenous component of the non-
neuronal cholinergic system in the process of cells migra-
tion. In the A549 cells, the concentration of acetylcholine
that is secreted in close proximity to the membrane M3
mAChR is likely to be much higher than that measured in
the supernatant. However, these values are similar to
the concentrations of exogenous acetylcholine that are
required to induce IL-8 release from A549 cells [31] and
leukotriene B4 release from 16-HBE cells [38]. In fact, the
epithelial cells express the machinery of the cholinergic
system, including the acetylcholine-synthesizing choline
acetyltransferase, the mAChRs and the acetylcholine-
hydrolyzing enzymes acetylcholinesterase and butyryl-
cholinesterase [31, 37]. Furthermore, the acetylcholine
analogue carbachol induced ASM cell migration in a
concentration-dependent manner and the carbachol-
induced cell migration event could be blocked by tiotro-
pium or 4-DAMP, suggesting that M3 mAChR stimulation
is indeed involved in ASM cell migration induced by the
chemokines from the stimulated A549 epithelial cells,
resulting in airway remodeling. The current scenario
strongly suggests a local, autocrine or paracrine role of
epithelial acetylcholine in regulating various aspects of
airway remodeling via the mAChRs. In addition to syn-
thesizing and releasing acetylcholine, the epithelial cells
can also be activated by acetylcholine, which exerts its
physiological effects via the activation of M3 mAChR.
The last part of our work focused on the signaling
pathways that jointly or individually regulate the ASM
cell migration induced by IL-8 and TGF-β1 from the ac-
tivated A549 epithelial cells in the presence or absence
of CSE. IL-8 expression requires the activation of NF-kB
and at least one or two MAPK pathways. In addition to
the Smad-mediated pathways, other pathways, such as
the MAPK and PI3K/Akt pathways, have been impli-
cated in TGF-β1 signaling [40, 41]. Several studies have
suggested that the p38, extracellular signal-regulated
kinase (ERK) and phosphoinositide 3-kinase (PI3K) sig-
naling pathways play important roles in regulating ASM
cell migration [8]. In the present study, we provide evi-
dence regarding the mechanism by which M3 mAChR
activation induces IL-8 and TGF-β1 release from the
A549 cells through phosphorylation of p38 and Akt,
thus causing the ASM cells to migrate toward the epi-
thelial cells. Cell migration was reduced by SB203580
(p38 MAPK inhibitor) and LY294002 (PI3K/Akt inhibitor),
respectively, suggesting that p38 and PI3K/Akt signaling
pathways were both involved in cell migration. Moreover,
the addition of both carbachol and CSE enhanced p38 and
Akt phosphorylation and was also inhibited by 4-DAMP,
showing that M3 mAChR activation can amplify the signal-
ing pathways that govern the CSE-induced IL-8 and TGF-
β1 expression. These findings reinforce and expand other
reported experiments showing that the phosphorylation of
proteins in the Smad2/3 and ERK pathways is involved in
the epithelial-mesenchymal transition triggered by the
TGF-β1 from the carbachol-stimulated A549 epithelial
cells, resulting in airway remodeling [42]. Moreover, acetyl-
choline mediates the release of IL-8 in human bronchial
epithelial cells by an NF-kB/ERK-dependent mechanism
[39], demonstrating the involvement of the p38 and PI3K/
Akt signaling pathways in CSE-induced ASM cell migration
via the activation of the M3 mAChR.
Conclusion
In summary, our study provides evidence that the non-
neuronal cholinergic system is involved in regulating
ASM cell migration. Lung epithelial cells secrete acetyl-
choline, which may function as an autocrine growth fac-
tor via the activation of M3 mAChR, to induce ASM cell
migration via the p38 and Akt signaling pathways. These
findings demonstrated that the M3 mAChR may be im-
portant therapeutic target for obstructive airway dis-
eases, as it regulates the effects of the epithelial-derived
chemokines on ASM cell migration, which results in
lung remodeling.
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